Thorne HealthTech, Inc. Enters Into Definitive Agreement To Be Acquired by L Catterton For $10.20 Per Share In Cash
Portfolio Pulse from Happy Mohamed
Thorne HealthTech, Inc. (NASDAQ:THRN) has entered into a definitive agreement to be acquired by L Catterton for $10.20 per share in cash, a 94% premium to the unaffected price. The transaction, valued at approximately $680 million, has been unanimously approved by Thorne's independent Special Committee and Board of Directors. The deal is expected to be completed in Q4 2023, subject to customary closing conditions and regulatory approvals.
August 28, 2023 | 12:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Thorne HealthTech is to be acquired by L Catterton for $10.20 per share in cash, a 94% premium to the unaffected price. The deal is expected to close in Q4 2023.
The acquisition of Thorne HealthTech by L Catterton at a significant premium is likely to have a positive impact on the stock price in the short term. The unanimous approval by Thorne's independent Special Committee and Board of Directors, as well as the expected completion in Q4 2023, adds certainty to the transaction.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100